[EN] FUSED BICYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE PYRAZOLE BICYCLIQUES CONDENSÉS EN TANT QU'INHIBITEURS DE KINASE
申请人:UCB PHARMA SA
公开号:WO2011058112A1
公开(公告)日:2011-05-19
A series of substituted pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives, being selective inhibitors of P13 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
一系列替代的吡唑并[3,4-b]吡啶和吡唑并[3,4-d]嘧啶衍生物,作为P13激酶酶的选择性抑制剂,在医学上具有益处,例如在治疗炎症、自身免疫、心血管、神经退行性、代谢、肿瘤、疼痛或眼科疾病方面。